Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756274 · ClinicalTrials.gov registry record · NA
Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
NCT01756274 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 162 participants.
The verdict
NCT01756274, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the performance of three Bayer Blood Glucose Monitoring Systems (BGMS) with neonatal blood. Blood samples used in this study were 'left-over samples'. The blood samples were from heel sticks of neonates, collected (into a tube) and sent to the laboratory. All meter Blood Glucose (BG) results were compared with capillary plasma results obtained with a reference laboratory glucose method (Cobas® 6000 instrument).
Interventions
- DEVICE Contour® PLUS BGMS
- DEVICE Contour® NEXT BGMS
- DEVICE Contour® Next EZ BGMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01756274
The ClinicalTrials.gov registry entry for NCT01756274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Contour® PLUS BGMS is the first listed.
NCT01756274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01756274 about?
NCT01756274 is a clinical study titled "Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates". The purpose of this study was to evaluate the performance of three Bayer Blood Glucose Monitoring Systems (BGMS) with neonatal blood. Blood samples used in this study were 'left-over samples'. The blood samples were from heel sticks of neonates, collected (into a tube) and sent to the laboratory. Al...
What is the current status of trial NCT01756274?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2012-12. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01756274?
The interventions under investigation include: Contour® PLUS BGMS (DEVICE), Contour® NEXT BGMS (DEVICE), Contour® Next EZ BGMS (DEVICE).
Who is sponsoring clinical trial NCT01756274?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.